January 29, 2020
JPMA President Joji Nakayama Now that details have been hammered out for the 2020 drug pricing reform this April, the Japan Pharmaceutical Manufacturers Association (JPMA) will seek two big themes towards the next reform in 2022 - a revamped system...read more